Tokyo, June 27 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062072) titled 'Functional effects of royal jelly-derived fatty acids (10-hydroxy-2-decenoic acid and 10-hydroxydecanoic acid) intake on maintaining and improving skin function in healthy adults: a systematic review' on June 26.
Study Type:
Others,meta-analysis etc
Primary Sponsor:
Institute - Yamada Bee Company, Inc.
Condition:
Condition - Healthy adults
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To evaluate whether oral intake of royal jelly-derived fatty acids (10-hydroxy-2-decenoic acid and 10-hydroxydecanoic acid) contributes to maintaining and improving skin function in healthy adults.
Basic objectives2 - Efficacy
Eligibility:
Age-lower limit - 18
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - P (Participant) : Healthy adults
I (Intervention) : Oral intake of foods containing royal jelly-derived fatty acids (10-hydroxy-2-decenoic acid and 10-hydroxydecanoic acid)
C (Comparison) : Oral intake of placebo foods
O (Outcome) : Evaluation of the effects on maintaining and improving skin function
S (Study Design) : Parallel-group or crossover randomized controlled trials
Key exclusion criteria - Studies that do not match the PICOS criteria
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2026 Year 06 Month 25 Day
Anticipated trial start date - 2026 Year 06 Month 29 Day
Last follow-up date - 2026 Year 08 Month 29 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000071005
Disclaimer: Curated by HT Syndication.
